|
|
||||||||
Center for Biomedical Research, Population Council, 1230 York Avenue, New York, NY 10021, USA
Correspondence: * corresponding author, mrobbiani{at}popcouncil.org
Dendritic cells (DCs) are white blood cells that coordinate innate and adaptive immunity. They are distributed within epithelia and mucosal-associated lymphoid tissues, positioned to entrap incoming pathogens or vaccines. Human immunodeficiency virus (HIV) and the non-human primate equivalent (SIV) exploit DCs to amplify infection, underscoring the need to harness strategies that promote presentation of virus by DCs to stimulate potent anti-viral immunity instead of virus transmission. Two main subsets of DCs need to be considered: myeloid (MDC) and plasmacytoid (PDC) subsets. Using the SIV-macaque system to advance oral vaccine research, we examined macaque PDC and MDC biology, identifying ways to activate DCs and boost antiviral immunity. Immunostimulatory oligodeoxyribonucleotides (ISS-ODNs) stimulated PDC/MDC mixtures to up-regulate co-stimulatory molecule expression and to secrete both IFN-
and IL-12. Additionally, ISS-ODNs augmented SIV-specific IFN-
responses induced by virus-bearing DCs. ISS-ODN-driven DC activation is being pursued to improve oral/nasopharyngeal mucosal vaccines and therapies against HIV.
KEY WORDS: Dendritic cells immunostimulatory oligodeoxyribonucleotides SIV macaque immunity
This article has been cited by other articles:
![]() |
M.C. Herzberg, A. Weinberg, and S.M. Wahl (C3) The Oral Epithelial Cell and First Encounters with HIV-1 Adv. Dent. Res., April 1, 2006; 19(1): 158 - 166. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® | Journal of Dental Research ® | Critical Reviews (1990-2004) |